These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 7512100
1. The effect of chronic alprazolam on sleep and bioamine metabolites in depression. Zarcone VP, Benson KL, Greene KA, Csernansky JG, Faull KF. J Clin Psychopharmacol; 1994 Feb; 14(1):36-40. PubMed ID: 7512100 [Abstract] [Full Text] [Related]
10. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040 [Abstract] [Full Text] [Related]
11. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. Fawcett J, Edwards JH, Kravitz HM, Jeffriess H. J Clin Psychopharmacol; 1987 Oct 15; 7(5):295-310. PubMed ID: 3316312 [Abstract] [Full Text] [Related]
14. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings. Aberg-Wistedt A, Ross SB, Jostell KG, Sjöquist B. Adv Biochem Psychopharmacol; 1984 Oct 15; 39():439-47. PubMed ID: 6205564 [No Abstract] [Full Text] [Related]
15. The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid. Przuntek H, Kuhn W. Adv Neurol; 1990 Oct 15; 53():445-9. PubMed ID: 1700583 [No Abstract] [Full Text] [Related]
18. [Depression and sleep--the status of current research]. Riemann D, Schnitzler M, Hohagen F, Berger M. Fortschr Neurol Psychiatr; 1994 Dec 15; 62(12):458-78. PubMed ID: 7835818 [Abstract] [Full Text] [Related]
19. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Kluge M, Schüssler P, Steiger A. Eur Neuropsychopharmacol; 2007 Jul 15; 17(8):527-31. PubMed ID: 17337164 [Abstract] [Full Text] [Related]
20. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment. Bäckman J, Alling C, Alsén M, Regnéll G, Träskman-Bendz L. Eur Neuropsychopharmacol; 2000 Sep 15; 10(5):341-9. PubMed ID: 10974605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]